{
  "trial_id": "NCT03532490",
  "trial_group": "obesity",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, Gender, Body Mass Index (BMI), Asthma Control Test (ACT) Score, Forced Expiratory Volume at one second (FEV1), Use of rescue inhaler, Nocturnal asthma awakening frequency, Emergency department/hospital visit for asthma, Prednisone course for asthma, Smoking history, History of bariatric surgery, Use of drugs metabolized by cytochrome P450, Current use of roflumilast or theophylline, Depression score (PHQ-9), Anxiety score (GAD-7)",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Smoking status",
          "Smoking history"
        ],
        [
          "Asthma Control Test at Visit 2 (V2)",
          "Asthma Control Test (ACT) Score"
        ],
        [
          "Forced expiratory volume at one second",
          "Forced Expiratory Volume at one second (FEV1)"
        ],
        [
          "Patient Health Questionnaire-9",
          "Depression score (PHQ-9)"
        ],
        [
          "General Anxiety Disorder-7",
          "Anxiety score (GAD-7)"
        ]
      ],
      "remaining_reference_features": [
        "Sex: Female",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment",
        "Age at asthma onset (years)",
        "Asthma Symptom Utility Index",
        "Marks Asthma Quality of Life",
        "Short form survey-36",
        "Gastrointestinal Symptom Rating Scale",
        "Forced Vital Capacity",
        "Forced Expiratory Volume/Forced vital capacity",
        "Methacholine PD20",
        "Greater than/equal to 1 unscheduled health visit for asthma in prior year",
        "Greater than/equal to 1 course of oral corticosteroids in prior year"
      ],
      "remaining_candidate_features": [
        "Gender",
        "Body Mass Index (BMI)",
        "Use of rescue inhaler",
        "Nocturnal asthma awakening frequency",
        "Emergency department/hospital visit for asthma",
        "Prednisone course for asthma",
        "History of bariatric surgery",
        "Use of drugs metabolized by cytochrome P450",
        "Current use of roflumilast or theophylline"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Asthma Control Test (ACT) Score, Forced Expiratory Volume in 1 Second (FEV1), Use of Rescue Inhaler, Nocturnal Asthma Awakening, Emergency Department/Hospital Visit for Asthma, Prednisone Course for Asthma,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Body Mass Index",
          "Body Mass Index"
        ],
        [
          "Asthma Control Test at Visit 2 (V2)",
          "Asthma Control Test (ACT) Score"
        ],
        [
          "Forced expiratory volume at one second",
          "Forced Expiratory Volume in 1 Second (FEV1)"
        ],
        [
          "Greater than/equal to 1 unscheduled health visit for asthma in prior year",
          "Emergency Department/Hospital Visit for Asthma"
        ],
        [
          "Greater than/equal to 1 course of oral corticosteroids in prior year",
          "Prednisone Course for Asthma"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Age at asthma onset (years)",
        "Asthma Symptom Utility Index",
        "Marks Asthma Quality of Life",
        "Patient Health Questionnaire-9",
        "General Anxiety Disorder-7",
        "Short form survey-36",
        "Gastrointestinal Symptom Rating Scale",
        "Forced Vital Capacity",
        "Forced Expiratory Volume/Forced vital capacity",
        "Methacholine PD20"
      ],
      "remaining_candidate_features": [
        "Use of Rescue Inhaler",
        "Nocturnal Asthma Awakening"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Asthma Control Test Score, FEV1, Use of rescue inhaler, Nocturnal asthma awakening, Emergency department/hospital visit or prednisone course for asthma, Smoking history.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Smoking status",
          "Smoking history"
        ],
        [
          "Asthma Control Test at Visit 2 (V2)",
          "Asthma Control Test Score"
        ],
        [
          "Forced expiratory volume at one second",
          "FEV1"
        ],
        [
          "Greater than/equal to 1 unscheduled health visit for asthma in prior year",
          "Emergency department/hospital visit or prednisone course for asthma"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Age at asthma onset (years)",
        "Asthma Symptom Utility Index",
        "Marks Asthma Quality of Life",
        "Patient Health Questionnaire-9",
        "General Anxiety Disorder-7",
        "Short form survey-36",
        "Gastrointestinal Symptom Rating Scale",
        "Forced Vital Capacity",
        "Forced Expiratory Volume/Forced vital capacity",
        "Methacholine PD20",
        "Greater than/equal to 1 course of oral corticosteroids in prior year"
      ],
      "remaining_candidate_features": [
        "Body Mass Index",
        "Use of rescue inhaler",
        "Nocturnal asthma awakening"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, BMI, FEV1, ACT score, smoking history, pack years, asthma duration, controller therapy, rescue inhaler use, nocturnal asthma awakening, ED/hospital visit, prednisone course, depression score (PHQ-9), anxiety score (GAD-7), comorbidities (COPD, liver cirrhosis, major psychiatric disorders).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Smoking status",
          "smoking history"
        ],
        [
          "Forced expiratory volume at one second",
          "FEV1"
        ],
        [
          "Asthma Control Test at Visit 2 (V2)",
          "ACT score"
        ],
        [
          "Greater than/equal to 1 unscheduled health visit for asthma in prior year",
          "ED/hospital visit"
        ],
        [
          "Greater than/equal to 1 course of oral corticosteroids in prior year",
          "prednisone course"
        ],
        [
          "Patient Health Questionnaire-9",
          "depression score (PHQ-9)"
        ],
        [
          "General Anxiety Disorder-7",
          "anxiety score (GAD-7)"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment",
        "Age at asthma onset (years)",
        "Asthma Symptom Utility Index",
        "Marks Asthma Quality of Life",
        "Short form survey-36",
        "Gastrointestinal Symptom Rating Scale",
        "Forced Vital Capacity",
        "Forced Expiratory Volume/Forced vital capacity",
        "Methacholine PD20"
      ],
      "remaining_candidate_features": [
        "BMI",
        "pack years",
        "asthma duration",
        "controller therapy",
        "rescue inhaler use",
        "nocturnal asthma awakening",
        "comorbidities (COPD, liver cirrhosis, major psychiatric disorders)."
      ]
    }
  }
}